# VCU Massey Cancer Center Support Grant

> **NIH NIH P30** · VIRGINIA COMMONWEALTH UNIVERSITY · 2020 · $149,964

## Abstract

OVERALL: PROJECT SUMMARY/ABSTRACT
Massey Cancer Center (MCC) at Virginia Commonwealth University (VCU) brings together faculty across the
university to foster interdisciplinary and transdisciplinary research strategies aimed at prevention, control, and
ultimately the cure of cancer through translation of basic, clinical, and population science. The overall goal of
research at MCC is to improve the health and lives of individuals affected by or at risk for cancer, with a
particular focus on the high cancer burden in the MCC catchment area, which has a high percentage of
underserved and minority populations. Collaborative research is conducted both within and among the 4
scientific programs in Cancer Cell Signaling, Cancer Molecular Genetics, Developmental Therapeutics, and
Cancer Prevention and Control, as well as through cross-cutting scientific themes. As a matrix cancer center
organized within the VCU Health Sciences division, MCC promotes collaborative research among faculty in the
schools of medicine, nursing, dentistry, and pharmacy. Translational research is facilitated through disease-
specific focus groups that engage basic, clinical, and prevention and control researchers, as well as clinical
care providers. MCC also engages members from the schools of engineering, humanities and sciences, and
social work to maximize transdisciplinary research collaborations. Developmental funds are used to support
the initial research endeavors of newly recruited faculty and to encourage innovative collaborative research
through peer-reviewed pilot research grants that require at least 2 collaborating investigators. To give
members access to new technologies and high-quality methodologies and to facilitate successful research,
MCC supports 7 shared resources: Microscopy, Lipidomics and Metabolomics, Flow Cytometry, Biostatistics,
Cancer Informatics, Tissue and Data Acquisition and Analysis, and Transgenic Mouse. To accelerate
translation and dissemination of research findings, MCC supports a full-service Clinical Trials Office that
coordinates movement of programmatic scientific concepts through multidisciplinary and disease-specific focus
groups into early-phase clinical trials and supports high-priority NCI-sponsored trials. Both clinical trials and
cancer care delivery research are extended to greater Virginia through a Minority Based NCI Community
Oncology Research Program (MU-NCORP). MCC members currently hold over $36 million in NCI-recognized
peer-reviewed (> 35% NCI) funding and of the 158 grants in the portfolio, 106 (56%) are highly cancer specific.
The research highlighted in this application stems from 1700 member publications in peer-reviewed journals
(~14% of which appear in journals with impact factors of 8 and above since 2012). The upward trajectory of
high-impact peer-reviewed collaborative research, guided by center strategic planning and evaluation,
illustrates the effectiveness of MCC senior leadership in organizing and coordinating...

## Key facts

- **NIH application ID:** 10243862
- **Project number:** 3P30CA016059-39S3
- **Recipient organization:** VIRGINIA COMMONWEALTH UNIVERSITY
- **Principal Investigator:** Robert A. Winn
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $149,964
- **Award type:** 3
- **Project period:** 1995-12-01 → 2022-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10243862

## Citation

> US National Institutes of Health, RePORTER application 10243862, VCU Massey Cancer Center Support Grant (3P30CA016059-39S3). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10243862. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*